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Describe role of Submitting/Presenting Trainee in this project (limit 150 words):
Dr. Issa and Dr. Kaur are co-primary investigators. We have collected pre-interventional
data, developed the algorithm, and will collect post-interventional data. We have also
educated residents on the GI service and distributed the algorithm to the residents as well
as the entire GI section.
Problem Statement/Question, Background/Project Intent (Aim Statement), Methods (include PDSA
cycles), Results, Conclusions limited to 500 words

Problem Statement/Question:
There is a lack of standardization/pediatric guidelines regarding thromboprophylaxis in pediatric
inflammatory bowel disease patients admitted for acute flare.

Background/Project Intent (Aim Statement):
Pediatric inflammatory bowel disease (IBD) patients in acute flare have 1.5 to 3-fold higher
risk of thromboembolism compared to the general population. Anticoagulation therapy is
recommended for pediatric IBD patients who have ≥ 1 risk factors for venous
thromboembolic events. At Children’s Mercy Hospital (CMH), approximately 80
patients/year are admitted for acute flare, of which, roughly 30% receive appropriate
thromboprophylaxis. Lack of standardization of thromboprophylaxis and an educational gap
amongst providers are significant barriers. Our goal is to standardize and improve the rates
of thromboprophylaxis in IBD patients admitted at CMH from 30% to 60% by 12/2020. The
development of a protocol will be associated with more consistent clinical care and lead to
successful patient related outcomes in terms of prevention of complications like venous
thromboembolism.

Methods (include PDSA cycles):
A retrospective chart review was done for IBD patients admitted from 06/2019-12/2019.
For those with acute flare, we assessed different variables including risk factors, duration of
hospitalization, and thromboprophylaxis measures. A thromboprophylaxis protocol was
created with our Hematology colleagues and will be initiated for IBD patients upon
admission. Elements include ambulation, adequate hydration, placing sequential
compression devices, and anti-coagulants for patients with history of thrombosis, family
history of thrombotic disorder <40 years of age, and those with a central line. The team will
document which thromboprophylaxis measures were implemented. Monthly emails will be
sent regarding implementation of the protocol. The protocol will be
posted in the workrooms and discussed at the monthly department IBD meeting.

Results:
Pre-intervention data: Out of 30 IBD patients admitted for acute flare at CMH, approximately
33% received thromboprophylaxis. Patients who were not admitted with acute flare were
excluded. Post-intervention data will be obtained and analyzed through 12/2020. Feedback
will be obtained from attendings and fellows during the monthly meeting.

Conclusions:
Potential hurdles in implementation include difficulty achieving full participation of the team
members and convincing providers of the clinical impact of the protocol. We will monitor our
data on a monthly basis to ensure sustainability and perform additional interventions as
necessary. Once post-interventional data is obtained, we plan to publish the findings as our
thromboprophylaxis protocol and implementation process could benefit CMH and other
institutions.

